Drug Shortage Report for MINT-MONTELUKAST
| Report ID | 45542 |
| Drug Identification Number | 02408635 |
| Brand name | MINT-MONTELUKAST |
| Common or Proper name | Montelukast |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL |
| Packaging size | 30 Count Blisters |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-04-09 |
| Estimated end date | 2018-04-30 |
| Actual end date | 2018-05-02 |
| Shortage status | Resolved |
| Updated date | 2018-05-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-05-04 | French | Compare |
| v3 | 2018-05-04 | English | Compare |
| v2 | 2018-04-12 | French | Compare |
| v1 | 2018-04-12 | English | Compare |
Showing 1 to 4 of 4